An Open Label Study of Gene Therapy Product in Spinal Muscular Atrophy Patients

Conditions: Spinal Muscular Atrophy Interventions: Drug: vesemnogene lantuparvovec Sponsors: Lantu Biopharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials